Early studies have shown that the abuse of alcohol, central stimulants, and opiates such as heroin destroys brain cells, reducing attention span and memory. However, new research has suggested that there may be a way to regain some of the lost attention and recall. It has recently been shown that brain cells targeted for early death by continued opiate use can be salvaged by injections of synthetic human growth hormone (GH). GH is a polypeptide hormone, normally secreted by the anterior pituitary gland, which stimulates cell growth and controls body metabolism. Recombinant human GH is currently used in replacement therapy to alleviate the symptoms of adults and children with GH deficiency syndrome. The recent observation that GH can reverse morphine-induced cell damage could open the door to new ways of treating and preventing damage from the abuse of opiates in addicts and also of treating cell damage induced by alcohol and central stimulants. This article reviews current knowledge of the somatotrophic axis, including GH and insulin-like growth factor-1 (IGF-1), in the brain and also discusses the potential use of GH/IGF-1 as agents for treatment of brain pathology in addictive diseases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S0074-7742(09)88014-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond.
Rev Endocr Metab Disord
November 2024
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
The regulation of growth hormone (GH) synthesis and secretion by somatotroph cells of the anterior pituitary is a highly complex process, mediated by a variety of neuroendocrine and peripheral influences. In particular, a key role is played by the hypothalamic peptides growth hormone-releasing hormone (GHRH) and somatostatin, which regulate the somatotroph axis with opposite actions, stimulating and inhibiting GH release, respectively. Since the discovery of GHRH about 50 years ago, many pathophysiological studies have explored the underlying intricate hormonal balance that regulates GHRH secretion and its interplay with the somatotroph axis.
View Article and Find Full Text PDFPreoperative predictors of biochemical remission in somatotroph adenoma resections: a single-institution retrospective review.
J Neurosurg
November 2024
Departments of1Neurological Surgery and.
Objective: There is persistent debate in the literature surrounding the true predictors of biochemical remission after resection of somatotroph adenoma. A multimodal analysis of a large number of patients is needed to better understand which patients may be at higher or lower risk for remission failure after surgery.
Methods: A retrospective review was performed on patients undergoing somatotroph adenoma resection.
IGF-I and GH Genes polymorphism and their association with milk yields, composition and reproductive performance in Holstein-Friesian dairy cattle.
BMC Vet Res
August 2024
Animal and Fish Production Department, Faculty of Agriculture (Al-Shatby), Alexandria University, Aflaton St, Alexandria City, 11865, Egypt.
Article Synopsis
- The study investigates the relationship between genetic variations in insulin-like growth factor (IGF-I) and growth hormone (GH) genes and their impact on milk yield and reproductive performance in a herd of 1000 Holstein-Friesian dairy cattle.
- Genetic analysis revealed distinct polymorphisms in the IGF-I and GH genes, showing specific alleles and genotypes that could correlate with production levels among the cows.
- The findings contribute to understanding how these genetic markers can influence dairy cattle performance and may guide future breeding strategies for improving milk production and quality.
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency.
Pituitary
October 2024
Department of Medicine IV, University Hospital, LMU Munich, München, Germany.
Purpose: It is unclear whether the age-related decline in the somatotropic axis stems from a reduced growth hormone (GH) production in the pituitary gland, or from a peripheral origin akin to an acquired GH resistance. With the help of a GHRH/arginine test, high-aged multimorbid hospitalized patients with IGF-I deficiency are to be tested to determine whether there is primarily a pituitary GH deficiency in the sense of a somatopause.
Methods: Seventeen multimorbid patients (eleven men and six women) with a mean age of 82 years, with IGF-I concentrations below two standard deviations of 30-year-old men and women were identified.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!